Studies Currently Enrolling

• 40 years and older
• History of smoking-current or former
• Have had bronchitis or lung infection in the last year
• On current therapy daily for COPD

 A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR) - Full Text View - ClinicalTrials.gov 

 Are you 60 years of age or older and have had a urinary tract infection (UTI) in the past two years? Are you interested in helping us find a way to prevent blood infections? If so, this clinical research study may be of interest to you. 

• 18-80
• 24 weeks with 28 week open label extension
• have had a cough that is unexplained and you have seen doctors for it

 BELLUS Health, Inc. - The Future of Treating Cough